 |
|
Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy
Charles J. Cho, Ho June Song, Gin Hyug Lee, Kee Don Choi, Yong-Hee Kim, Jin-Sook Ryu, Sung-Bae Kim, Jong Hoon Kim, Seung-Il Park, Hwoon-Yong Jung
Korean J Intern Med. 2017;32(3):443-451. Published online 2016 Mar 14 DOI: https://doi.org/10.3904/kjim.2015.185
|
|
Citations to this article as recorded by
 Efficacy and Safety of Immune Checkpoint Inhibitor Combination Therapy for Dysphagia in Patients with Advanced Esophageal Cancer
Yurika Nakayama, Takayuki Ando, Hiroaki Takagi, Iori Motoo, Yuko Ueda, Miho Sakumura, Shinya Kajiura, Saeko Takahashi, Seitaro Shimada, Yusuke Takashima, Haruka Fujinami, Kohei Ogawa, Hotaka Tamura, Ayumu Hosokawa, Ichiro Yasuda
Journal of Clinical Medicine.2024; 13(16): 4806. CrossRef Esophageal stenosis as an independent factor of poor prognosis in patients with ESCC treated with definitive chemoradiotherapy
Zhongxuan Gui, Wenjun Hu, Qi Kong, Can Liu, Yuechen Xu, Fan Wang
Future Oncology.2022; 18(38): 4193. CrossRef Does oesophageal stenosis have any impact on survival of oesophageal cancer patients?
Han-Yu Deng, Gang Li, Jun Luo
Interactive CardioVascular and Thoracic Surgery.2018; 27(3): 384. CrossRef Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma
Hae Jin Shin, Hee Seok Moon, Sun Hyung Kang, Jae Kyu Sung, Hyun Yong Jeong, Seok Hyun Kim, Byung Seok Lee, Ju Seok Kim, Gee Young Yun
Medicine.2017; 96(51): e9441. CrossRef
|